Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
10.93
-0.22 (-1.97%)
At close: Dec 5, 2025, 4:00 PM EST
11.10
+0.17 (1.56%)
After-hours: Dec 5, 2025, 7:17 PM EST
Avantor Revenue
Avantor had revenue of $1.62B in the quarter ending September 30, 2025, a decrease of -5.28%. This brings the company's revenue in the last twelve months to $6.58B, down -3.59% year-over-year. In the year 2024, Avantor had annual revenue of $6.78B, down -2.64%.
Revenue (ttm)
$6.58B
Revenue Growth
-3.59%
P/S Ratio
1.13
Revenue / Employee
$487,052
Employees
13,500
Market Cap
7.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.78B | -183.60M | -2.64% |
| Dec 31, 2023 | 6.97B | -545.20M | -7.26% |
| Dec 31, 2022 | 7.51B | 126.30M | 1.71% |
| Dec 31, 2021 | 7.39B | 992.50M | 15.52% |
| Dec 31, 2020 | 6.39B | 353.30M | 5.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
AVTR News
- 2 days ago - Avantor® Appoints Sanjeev Mehra to its Board of Directors - PRNewsWire
- 2 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor - GlobeNewsWire
- 4 days ago - Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts Farmers Market and Avantor to Contact the Firm Before Upcoming Deadlines - GlobeNewsWire
- 5 days ago - UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor - Newsfile Corp
- 5 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 29, 2025 in Avantor, Inc. Lawsuit - AVTR - PRNewsWire
- 11 days ago - Avantor® Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology - PRNewsWire
- 12 days ago - Touchstone Mid Cap Fund Q3 2025 Portfolio Review - Seeking Alpha
- 14 days ago - Is Avantor Stock a Buy After the CEO Scooped Up Nearly $1 Million in Shares? - The Motley Fool